Freedo mm: A Multicenter Observational Study of Multiple Myeloma in Second Relapse in Colombia

被引：0
|
作者：
Quintero, Guillermo [1 ,2 ,3 ]
Aruachan, Sandra [4 ]
Figueroa Emiliani, Jair [5 ]
Galvez, Kenny [6 ]
Antonio Salazar, Luis [7 ,8 ]
Diaz, Melissa [9 ]
Camila Buitrago, Diana [9 ]
Martinez-Cordero, Humberto [10 ,11 ]
Saavedra, Juliana [12 ]
机构：
[1] Fdn SantaFe Bogota, Bogota, Colombia
[2] Univ los Andes, Bogota, Colombia
[3] Inst Cancerol Carlos Ardila Lulle, Bogota, Colombia
[4] IMAT Oncomed AUNA, Monteria, Colombia
[5] Hosp Univ Mayor Mederi, Bogota, Colombia
[6] Hosp Pablo Tobon Uribe, Medellin, Colombia
[7] Clin FOSCAL, Hematol & Hematopoiet Stem Cell Transplantat Unit, Bucaramanga, Colombia
[8] Univ Autonoma Bucaramanga, Fac Hlth Sci, Floridablanca, Colombia
[9] IQVIA, Bogota, Colombia
[10] Inst Nacl Cancerol, Unidad Hematooncol, Ctr Excelencia Mieloma multiple, Bogota, Colombia
[11] Hosp Mil Cent, Unidad hematol & trasplante medula osea, Bogota, Colombia
[12] Sanofi, Bogota, Colombia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Response to bortezomib therapy for multiple myeloma (MM) in actual clinical practice: Preliminary effectiveness findings of an international observational study
    Delforge, Michel
    Katodritou, Eirini
    Zervas, Konstantinos
    Sargin, Deniz
    Hulin, Cyrille
    Linderholm, Mats
    Verrou, Evgenia
    Poon, Vicki
    Dhawan, Ravinder
    BLOOD, 2007, 110 (11) : 284B - 284B
  • [42] Prospective Observational Study of 110 Multiple Myeloma (MM) Patients On Monthly Versus 3 Monthly Infusion of Zoledronic Acid
    Badros, Ashraf Z.
    Philip, Sunita
    Lesho, Patricia
    Weikel, Dianna
    Goloubeva, Olga
    Sadowska, Mariola
    Lapidus, Rena
    Hester, Lisa
    Milliron, Todd
    Meiller, Timothy
    BLOOD, 2012, 120 (21)
  • [43] Detection of multiple myeloma (MM) in the emergency laboratory: A case study
    Mayan Santos, L.
    Herrero Castellano, S.
    Rubio Lanchas, S.
    Anibarro Miralles, I.
    Marcos Sanchez, H.
    Trapiello Fernandez, W.
    Velasco De Cos, G.
    Golvano Guerrero, E. M.
    Calvo Nieves, M. D.
    CLINICA CHIMICA ACTA, 2024, 558
  • [44] Investigation of Second Primary Malignancies (SPM) in Multiple Myeloma (MM) Patients Treated with Lenalidomide
    Minton, N.
    Castaneda, C.
    Weiss, L.
    Brandenburg, N.
    Gary, D.
    Freeman, J.
    Delap, R.
    Knight, R.
    Glasmacher, A.
    Rupalla, K.
    Zhang, J.
    Yu, Z.
    DRUG SAFETY, 2011, 34 (10) : 951 - 951
  • [45] Management and Outcomes in Second and/or Third Relapse in Patients With Multiple Myeloma in the Real-Life Setting: EMMY Study Results
    Chalopin, Thomas
    Decaux, Olivier
    Royer, Bruno
    Caillot, Denis
    Bobin, Arthur
    Belhadj, Karim
    Macro, Margaret
    Karlin, Lionel
    Jacquet, Caroline
    Mohty, Mohamad
    Frenzel, Laurent
    Sonntag, Cecile
    Fontan, Jean
    Rigaudeau, Sophie
    Jaccard, Arnaud
    Sanhes, Laurence
    Chaoui, Driss
    Vincent, Laure
    Dib, Mamoun
    Joly, Bertrand
    Benramdane, Riad
    Dervite, Isabelle
    Le Calloch, Ronan
    Hulin, Cyrille
    Perrot, Aurore
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S255 - S256
  • [46] Second primary B-ALL after exposure to lenalidomide for multiple myeloma: A US multicenter study.
    Lakshman, Arjun
    Jensen, Jeffrey Lee
    Chakraborty, Rajshekhar
    Shaw, Gene
    Jevremovic, Dragan
    Shi, Min
    Cook, James R.
    Monaghan, Sara A.
    Abeykoon, Jithma P.
    Parrondo, Ricardo
    Bergsagel, Peter Leif
    Agha, Mounzer E.
    Rubinstein, Sam
    Coombs, Catherine Callaghan
    Ito, Sawa
    Shah, Mithun Vinod
    Advani, Anjali S.
    Baughn, Linda
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Management of biochemical relapse during lenalidomide maintenance therapy post asct in multiple myeloma: A descriptive observational study of a single institution
    El Sayed, Rola
    Haibe, Yolla
    Moukalled, Nour
    Massoud, Radwan
    Kort, Jeries
    Matar, Charbel
    Zahreddine, Ammar
    Bazarbachi, Ali
    El-Cheikh, Jean
    BONE MARROW TRANSPLANTATION, 2019, 54 : 505 - 505
  • [48] Management of Biochemical Relapse during Lenalidomide Maintenance Therapy Post ASCT in Multiple Myeloma: A Descriptive Observational Study of a Single Institution
    El Sayed, Rola
    Haibe, Yolla
    Moukalled, Nour
    Massoud, Radwan
    Haffar, Basel
    Zahreddine, Ammar
    Bazarbachi, Ali
    El Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S254 - S254
  • [49] Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)
    Jung, Eun Hee
    Byun, Ja Min
    Shin, Dong-Yeop
    Do, Young Rok
    Jo, Jae-Cheol
    Lee, Sang Min
    Yoon, Sung-Soo
    CANCER MEDICINE, 2023, 12 (08): : 9186 - 9193
  • [50] A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
    Yuichi Horigome
    Masaki Iino
    Yoriko Harazaki
    Takahiro Kobayashi
    Hiroshi Handa
    Yasushi Hiramatsu
    Taiga Kuroi
    Kazuki Tanimoto
    Kosei Matsue
    Masahiro Abe
    Tadao Ishida
    Shigeki Ito
    Hiromi Iwasaki
    Junya Kuroda
    Hirohiko Shibayama
    Kazutaka Sunami
    Hiroyuki Takamatsu
    Hideto Tamura
    Toshiaki Hayashi
    Kiwamu Akagi
    Takahiro Maeda
    Takahiro Yoshida
    Ikuo Mori
    Tomohiro Shinozaki
    Shinsuke Iida
    Annals of Hematology, 2024, 103 : 475 - 488
12345